Fund holdings · portfolios to September 2026
Mutual funds holding Molbio Diagnostics
30 mutual funds held Molbio Diagnostics (MOLBIO) in their portfolios to September 2026: 30 active funds and 0 index funds and ETFs.
What active funds did in September
1 increased, 1 opened a new position, 7 reduced and 2 exited.
2 increased9 reduced
The 10 largest holders, by weight in the fund
| Fund | Weight | In September |
|---|---|---|
| Kotak Healthcare Fund | 5.08% | Unchanged |
| Kotak Aggressive Hybrid Fund | 2.17% | Unchanged |
| HDFC Pharma and Healthcare Fund | 2.01% | Unchanged |
| Edelweiss Recently Listed IPO Fund | 1.95% | Unchanged |
| Mirae Asset Healthcare Fund | 1.77% | Unchanged |
| Kotak Contra Fund | 1.31% | Unchanged |
| PGIM India Retirement Fund | 1.19% | Unchanged |
| WhiteOak Capital Pharma and Healthcare Fund | 1.15% | Unchanged |
| Kotak Consumption Fund | 1.14% | Unchanged |
| Mirae Asset Flexi Cap Fund | 1.05% | Reduced |
All 30 funds that hold MOLBIO, and its active holders month by month
Loading…
Funds publish their portfolios once a month, within about ten days of the month end. A count of funds, not a call on the stock: read it beside the stage and the trend on Molbio Diagnostics’s page.